We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.89B
AUM Growth
+$125M
(+3.3%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-5.82%
Top 10 Holdings %
Top 10 Hldgs %
15.92%
Holding
230
New
17
Increased
95
Reduced
68
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATMI
A T M I INC
ATMI
|
+$32.5M |
| 2 |
Deckers Outdoor
DECK
|
+$29.6M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$24.2M |
| 4 |
Brinker International
EAT
|
+$21.4M |
| 5 |
GIMO
Gigamon Inc.
GIMO
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$40.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$39M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$37.5M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$31.6M |
| 5 |
BID
Sotheby's
BID
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.66% |
| 2 | Consumer Discretionary | 15.66% |
| 3 | Healthcare | 15.51% |
| 4 | Industrials | 11.08% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFM
126
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $11M | 0.28% |
272,632
-13,528
| -5% | -$629K |
|
|
SCMP
127
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $11M | 0.28% |
1,171,399
+26,600
| +2% | +$190K |
|
|
CYNO
128
DELISTED
Cynosure, Inc. Class A
CYNO
| $11M | 0.28% |
412,911
+27,918
| +7% | +$671K |
|
129
Sarepta Therapeutics
SRPT
$1.77B
| $11M | 0.28% |
538,504
+195,344
| +57% | +$5.8M |
|
|
MLNX
130
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $10.9M | 0.28% |
272,700
+148,200
| +119% | +$5.65M |
|
131
Progress Software
PRGS
$1.76B
| $10.6M | 0.27% |
409,301
+35,231
| +9% | +$912K |
|
|
VASC
132
DELISTED
Vascular Solutions Inc
VASC
| $10.5M | 0.27% |
454,061
+32,856
| +8% | +$644K |
|
|
ELOS
133
DELISTED
Syneron Medical Ltd
ELOS
| $10.4M | 0.27% |
848,804
+69,730
| +9% | +$724K |
|
|
OPLN
134
Openlane
OPLN
$4.54B
| $10.4M | 0.27% |
929,720
-1,231,964
| -57% | -$13.4M |
|
135
Oxford Industries
OXM
$552M
| $10.3M | 0.27% |
128,000
| – | – |
|
136
Littelfuse
LFUS
$11.6B
| $10.2M | 0.26% |
110,000
| – | – |
|
|
GENT
137
DELISTED
GENTIUM SPA ADS
GENT
| $10.1M | 0.26% |
176,400
-50,100
| -22% | -$2.23M |
|
138
Abercrombie & Fitch
ANF
$5B
| $10M | 0.26% |
305,000
-32,000
| -9% | -$1.1M |
|
|
HIBB
139
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $10M | 0.26% |
149,289
-44,081
| -23% | -$2.69M |
|
|
MSCC
140
DELISTED
Microsemi Corp
MSCC
| $9.76M | 0.25% |
391,300
| – | – |
|
|
EVRI
141
DELISTED
Everi Holdings
EVRI
| $9.71M | 0.25% |
971,581
| – | – |
|
|
STNR
142
DELISTED
STEINER LEISURE LTD
STNR
| $9.68M | 0.25% |
196,715
-76,590
| -28% | -$4.34M |
|
143
Salesforce
CRM
$158B
| $9.38M | 0.24% |
170,000
-236,560
| -58% | -$12.7M |
|
|
SLTM
144
DELISTED
SOLTA MED INC (DE)
SLTM
| $9.18M | 0.24% |
3,110,126
+139,282
| +5% | +$304K |
|
145
MarineMax
HZO
$788M
| $9.06M | 0.23% |
563,481
+57,372
| +11% | +$866K |
|
146
Talphera
TLPH
$74.2M
| $8.97M | 0.23% |
39,644
+16,225
| +69% | +$2.82M |
|
147
Meritage Homes
MTH
$4.86B
| $8.37M | 0.22% |
348,700
| – | – |
|
148
Titan Machinery
TITN
$445M
| $8.35M | 0.21% |
468,683
+36,573
| +8% | +$617K |
|
149
Harvard Bioscience
HBIO
$29.2M
| $8.1M | 0.21% |
172,396
+39,266
| +29% | +$1.72M |
|
|
RYL
150
DELISTED
RYLAND GROUP INC
RYL
| $7.82M | 0.2% |
180,200
| – | – |
|
Similar funds
HBT
BC
SW
WFMPM
AG
TA
ACP
TP
Granahan Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Granahan Investment Management held 230 positions worth $3.89B, up 3.3% from $3.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Granahan Investment Management withdrew a net $226M in Q4 2013, closing 21 positions and reducing 68 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Granahan Investment Management opened a new position in Deckers Outdoor worth $33.8M.
- Granahan Investment Management's largest Q4 2013 buy was Deckers Outdoor: 2,399,400 shares worth $33.8M.
- Granahan Investment Management added most to A T M I INC in Q4 2013, an estimated $32.5M increase.
- Granahan Investment Management's biggest Q4 2013 reduction was Sotheby's, cutting an estimated $27.7M.
- Granahan Investment Management fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $40.1M.
- Granahan Investment Management's ten largest holdings make up 16% of its $3.89B portfolio in Q4 2013.
- Granahan Investment Management opened 17 new positions and closed 21 in Q4 2013.
- Granahan Investment Management's portfolio value rose 3.3% quarter-over-quarter to $3.89B.
Based on Granahan Investment Management's 13F filing for Q4 2013, filed 30 Jan 2014.